304: The Revised Substance Use Disorder Privacy Regulations of 42 C.F.R. Part 2  


Richard Chapman, Chief Privacy Officer, University of Kentucky HealthCare 

Litany Webster, Compliance Manager, University of Kentucky HealthCare 

Glena Jarboe, Program Manager, University of Kentucky HealthCare

  • In 2017, for the first time in 30 years and in the midst of the ongoing opioid epidemic in the United States, federal regulators revised 42 CFR Part 2, which governs the confidentiality of a patient’s substance use disorder records and information
  • These substantive revisions represented SAMHSA’s effort to modernize the Part 2 regulations in light of the significant technological and regulatory changes in the healthcare system since Part 2’s last revision in 1987
  • This session will provide an overview of Part 2, discuss some of the more significant revisions from the final rule, including the revised patient consent requirements, and explore some of the practical compliance challenges faced by Part 2 providers

Presentation & handouts

To save the video to your computer right-click the link above then choose SAVE TARGET AS (or SAVE LINK AS) then save the file.